42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-656838
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 98ed2d5a-96d2-4b88-aa53-a4823d9729ce
[Document ID] => 656838
[Document naam] => CDA-Pfizer 22-9-2020.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/document/VWS-WOO-08-656838
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-656838
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz
[DocumentPublicationDate] => 22 september 2020
[DocumentStatusCheckedDate] => 2026-04-28 21:55:47.42916
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 03:07:17
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 03:07:17
)
Document: VWS-WOO-08-656838
Klik om te vergroten
Document correcties
Geregistreerde datum: 20200922
Geregistreerde documentnaam: CDA-Pfizer 22-9-2020.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 03:52:45 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/inventory | 2026-03-11 03:52:45 |
| Request_Omvang publicatie | 8.342 documenten waarvan 4.012 openbaar gemaakt Inventarislijst | 2026-03-11 03:52:45 |
| Request_Omvang publicatie_paginas | 8.342 | 2026-03-11 03:52:45 |
| About_Gelakte gegevens | 10.2a Internationale betrekkingen 10.2e Eerbiediging van de persoonlijke levenssfeer 10.2g Het voorkomen van onevenredige bevoordeling of benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-02 07:49:21 |
| document_SectionDownloadButton | 1 | 2025-09-02 07:49:21 |
| About_Gelakte gegevens_linkhref_4 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-02 07:49:21 |
| About_Datum document | 22 september 2020 | 2025-06-22 23:36:46 |
| About_Type bronbestand | PDF, 8 pagina's | 2025-06-22 23:36:46 |
| About_Type bronbestand_paginas | 8 | 2025-06-22 23:36:46 |
| About_Download als | PDF (4.01 MB) | 2025-06-22 23:36:46 |
| About_Documentnummer | 656838 | 2025-06-22 23:36:46 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkname_1 | 10.2a Internationale betrekkingen | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkhref_2 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkname_2 | 10.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkhref_3 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkname_3 | 10.2g Het voorkomen van onevenredige bevoordeling of benadeling | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkname_4 | Laat het ons weten | 2025-06-22 23:36:46 |
| document_SectionRequest | 1 | 2025-06-22 23:36:46 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode september 2020 | 2025-06-22 23:36:46 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz | 2025-06-22 23:36:46 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode september 2020 | 2025-06-22 23:36:46 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 25 februari 2022 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en medicatie over de periode september 2020. | 2025-06-22 23:36:46 |
| Request_Periode | September 2020 | 2025-06-22 23:36:46 |
| Request_Type besluit | Wob-besluit | 2025-06-22 23:36:46 |
| Request_Datum besluit | 25 februari 2022 | 2025-06-22 23:36:46 |
| document_documentName | CDA-Pfizer 22-9-2020.pdf | 2025-06-22 23:36:46 |
| document_documentType | 2025-06-22 23:36:46 | |
| document_documentPublicationDate | 2020-09-22 | 2025-06-22 23:36:46 |
| document_documentNumber | VWS-WOO-08-656838 | 2025-06-22 23:36:46 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:36:46 |
| document_SectionAbout | 1 | 2025-06-22 23:36:46 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:36:46 |
| document_SectionHistory | 1 | 2025-06-22 23:36:46 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:36:46 |
| About_Gelakte gegevens | 10.2a Internationale betrekkingen 10.2e Eerbiediging van de persoonlijke levenssfeer 10.2g Het voorkomen van onevenredige bevoordeling of benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:36:46 |
| About_Gelakte gegevens_linkhref_4 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over CDA-Pfizer 22-9-2020.pdf (documentnummer 1ef8fb29-1c4a-613e-9845-fb42b720b124) | 2025-06-22 23:36:46 |
| Request_Omvang openbaarmaking | 8.330 documenten, 23.793 pagina's Inventarislijst | 2025-06-22 23:36:46 |
| Request_Omvang openbaarmaking_documenten | 8.330 | 2025-06-22 23:36:46 |
| Request_Omvang openbaarmaking_paginas | 23.793 | 2025-06-22 23:36:46 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/inventory | 2025-06-22 23:36:46 |
| History Datum_1 | 21 oktober 2024 16:27 | 2025-06-21 02:20:12 |
| History Actie_1 | Bronbestand toegevoegd (pdf, 4.01 MB) | 2025-06-21 02:20:12 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/document/1ef8fb29-1c4a-613e-9845-fb42b720b124 | 2025-04-19 13:37:15 |
| DocumentDownload_linkname | Download (pdf, 4.01 MB) | 2025-04-19 13:37:15 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-656838.pdf | 2025-04-19 13:37:15 |
Archiefversies (9 rijen)
Archiefrij 1 — 2025-11-21 15:27:21
fromFile: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip
documentName: VWS-WOO-08-656838.pdf
documentType: pdf
documentCompressedSize: 3299506
documentSize: 4204847
documentCompressRatio: 78.46910957758986
documentDateModified: 2025-10-09 13:15:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:27:21
lastSeen: 2025-11-21 15:27:21
text: 656838
DocuSign Envelope ID |
10
2g
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a
This Confidential Disclosure Agreement
Mutual Disclosure
“Agreement”
is effective as of September 16 2020
“Effective
Date” and is made
Among
Pfizer Inc a corporation organized and existing under the laws of Dela...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a3e42c99266f4383704e8a2978fae2d28474339cb91a94cdfec2402d1256122c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 81841e5a-3aff-4835-9cf8-6835e43759ca
textDigestSHA256: 0a5c49c13e056d4ebdf754dbbdc3aec802e1c35249133a0c7d709af30474c9a6
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 2 — 2025-11-21 15:15:27
fromFile: VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip
fromFilePath: archieven_files\VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip
documentName: VWS-WOO-08-656838.pdf
documentType: pdf
documentCompressedSize: 3299506
documentSize: 4204847
documentCompressRatio: 78.46910957758986
documentDateModified: 2025-10-09 13:15:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:15:27
lastSeen: 2025-11-21 15:15:27
text: 656838
DocuSign Envelope ID |
10
2g
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a
This Confidential Disclosure Agreement
Mutual Disclosure
“Agreement”
is effective as of September 16 2020
“Effective
Date” and is made
Among
Pfizer Inc a corporation organized and existing under the laws of Dela...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a3e42c99266f4383704e8a2978fae2d28474339cb91a94cdfec2402d1256122c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: bce96d3a-c1be-4a4b-83b8-1b22a2613935
textDigestSHA256: 0a5c49c13e056d4ebdf754dbbdc3aec802e1c35249133a0c7d709af30474c9a6
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 3 — 2025-09-08 18:28:58
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/temp/VWS-WOO-08-656838-CDA-Pfizer_22-9-2020.pdf
documentName: VWS-WOO-08-656838-CDA-Pfizer_22-9-2020.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 4204847
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:28:58
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:28:58
lastSeen: 2025-09-08 18:28:58
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a3e42c99266f4383704e8a2978fae2d28474339cb91a94cdfec2402d1256122c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: folder_import_51888_ede9e9493fe7907c59d7f67746d331c0
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 4 — 2025-09-07 17:23:37
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-656838.pdf
documentName: VWS-WOO-08-656838.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 4204847
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:23:37
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:23:37
lastSeen: 2025-09-07 17:23:37
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a3e42c99266f4383704e8a2978fae2d28474339cb91a94cdfec2402d1256122c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_37573_2f5fb162f98784514c641a3b9fca3861
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 5 — 2025-09-04 16:18:27
fromFile: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip
documentName: VWS-WOO-08-656838.pdf
documentType: pdf
documentCompressedSize: 3299506
documentSize: 4204847
documentCompressRatio: 78.46910957758986
documentDateModified: 2025-05-01 21:05:18
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:18:27
lastSeen: 2025-11-21 13:47:41
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a3e42c99266f4383704e8a2978fae2d28474339cb91a94cdfec2402d1256122c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip_2347
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 6 — 2025-05-22 11:41:58
fromFile: VWS-WOO-3324842-1025145-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3324842-1025145-wjz.zip
documentName: VWS-WOO-08-656838.pdf
documentType: pdf
documentCompressedSize: 3299506
documentSize: 4204847
documentCompressRatio: 78.46910957758986
documentDateModified: 2025-05-01 21:05:18
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-05-22 11:41:58
lastSeen: 2025-05-22 11:41:58
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 422737
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 7 — 2025-02-27 09:25:02
fromFile: 2023.057-VWS-WOO-3324842-1025145-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3324842-1025145-wjz.zip
documentName: VWS-WOO-08-656838-CDA-Pfizer_22-9-2020.pdf
documentType: pdf
documentCompressedSize: 3295143
documentSize: 4204847
documentCompressRatio: 78.36534837058281
documentDateModified: 2024-12-10 12:02:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:02
lastSeen: 2025-02-27 09:25:02
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 217439
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 8 — 2025-02-18 12:36:08
fromFile: Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip
documentName: VWS-WOO-08-656838-CDA-Pfizer_22-9-2020.pdf
documentType: pdf
documentCompressedSize: 3295143
documentSize: 4204847
documentCompressRatio: 78.36534837058281
documentDateModified: 2024-12-04 10:53:58
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:36:08
lastSeen: 2025-02-18 12:36:08
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 178016
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
Archiefrij 9 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip
documentName: VWS-WOO-08-656838-CDA-Pfizer_22-9-2020.pdf
documentType: pdf
documentCompressedSize: 3295143
documentSize: 4204847
documentCompressRatio: 78.36534837058281
documentDateModified: 2024-10-21 17:04:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: 656838
102g DocuSign Envelope ID
|
CONFIDENTIAL DISCLOSURE AGREEMENT
Two \\a Mutual Disclosure
This Confidential Disclosure Agreement “Agreement”iseffective asofSeptember 162020 “Effective
Date” and ismade
Among
Pfizer Inc acorporation organized andexistingunder thelaws ofDelaware with offices at235...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 53663
textDigestSHA256: 803d6ee5470d1b6a8aaf5a99f2185c2ad92f41261a5c8dad8b05aa168b129bad
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-656838
(dit is ook een speeltuin)